Coolestaam

CO-OLESTA AM

Olmesartan Medoxomil

SEARLE PAKISTAN (PVT.) LTD.

Drug Identity

Active Ingredient
Olmesartan Medoxomil
Drug Class
Cardiac Care
0

How to Take It

Dosage information not available for this product.

Safety Alerts

Hepatic or severe renal impairment, cholestasis, biliary obstructive disorders, refractory hypoka-laemia, hypercalcaemia, hyponatraemia, symptomatic hyperuricaemia

Important Warnings

Salt or volume depletion, severe congestive heart failure, renal disease, renal artery stenosis, aortic or mitral valve stenosis, obstructive hypertrophic cardiomyopathy, primary aldosteronism, diabetes, mild to moderate renal impairment
monitor serum electrolytes, creatinine and uric acid

Side Effects

Arthritischest paincoughfatigueGI disturbanceshaematuriahypertriglyceridaemiahyperuricaemiainfluenza-like symptomsmusculoskeletal painperipheral oedemapharyngitisrhinitisurinary-tract infection. Rare: Anginavertigo

Drug Interactions

Lithium
K-supplement
K+-sparing diuretics
salt substitutes
baclofen
NSAIDs
amifostine
alcohol

Pregnancy & Lactation

Pregnancy
Contraindicated in pregnancy.
Lactation
Not recommended.

Price Intelligence

Rs 490
Servaid observed price · as of 30 July 2026
No approved ceiling matched to this exact pack and strength.
Prices across sources
ServaidRs 490

Should you consider an alternative?

Other options containing Olmesartan Medoxomil, and what they are not.

For pharma professionalsCompany, market and opportunity intelligence

Company

339
brands
413
molecules
1
alerts

Prices as of 30 July 2026 · DRAP ceiling as of 30 July 2026 · schema v3-SKU

For medicine intelligence and professional reference only. Not medical advice.